BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28130063)

  • 1. Effects of control interventions on Clostridium difficile infection in England: an observational study.
    Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Golubchik T; Harding RM; Wilson DJ; Griffiths D; Vaughan A; Finney JM; Wyllie DH; Oakley SJ; Fawley WN; Freeman J; Morris K; Martin J; Howard P; Gorbach S; Goldstein EJC; Citron DM; Hopkins S; Hope R; Johnson AP; Wilcox MH; Peto TEA; Walker AS; Crook DW;
    Lancet Infect Dis; 2017 Apr; 17(4):411-421. PubMed ID: 28130063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse sources of C. difficile infection identified on whole-genome sequencing.
    Eyre DW; Cule ML; Wilson DJ; Griffiths D; Vaughan A; O'Connor L; Ip CLC; Golubchik T; Batty EM; Finney JM; Wyllie DH; Didelot X; Piazza P; Bowden R; Dingle KE; Harding RM; Crook DW; Wilcox MH; Peto TEA; Walker AS
    N Engl J Med; 2013 Sep; 369(13):1195-205. PubMed ID: 24066741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network.
    Williamson CHD; Stone NE; Nunnally AE; Hornstra HM; Wagner DM; Roe CC; Vazquez AJ; Nandurkar N; Vinocur J; Terriquez J; Gillece J; Travis J; Lemmer D; Keim P; Sahl JW
    Microb Genom; 2019 Jul; 5(7):. PubMed ID: 31107202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile.
    Dingle KE; Freeman J; Didelot X; Quan TP; Eyre DW; Swann J; Spittal WD; Clark EV; Jolley KA; Walker AS; Wilcox MH; Crook DW
    mBio; 2023 Apr; 14(2):e0024323. PubMed ID: 37017518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019.
    Plankaova A; Brajerova M; Capek V; Balikova Novotna G; Kinross P; Skalova J; Soltesova A; Drevinek P; Krutova M
    Int J Antimicrob Agents; 2023 Jul; 62(1):106824. PubMed ID: 37116667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
    Finsterwalder SK; Loncaric I; Cabal A; Szostak MP; Barf LM; Marz M; Allerberger F; Burgener IA; Tichy A; Feßler AT; Schwarz S; Monecke S; Ehricht R; Ruppitsch W; Spergser J; Künzel F
    Zoonoses Public Health; 2022 Sep; 69(6):673-681. PubMed ID: 35546073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.
    Eyre DW; Fawley WN; Rajgopal A; Settle C; Mortimer K; Goldenberg SD; Dawson S; Crook DW; Peto TEA; Walker AS; Wilcox MH
    Clin Infect Dis; 2017 Aug; 65(3):433-441. PubMed ID: 28575285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence.
    Kumar N; Miyajima F; He M; Roberts P; Swale A; Ellison L; Pickard D; Smith G; Molyneux R; Dougan G; Parkhill J; Wren BW; Parry CM; Pirmohamed M; Lawley TD
    Clin Infect Dis; 2016 Mar; 62(6):746-752. PubMed ID: 26683317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated
    Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Marwick CA; Coia J; Brown D; Buchanan S; Ijaz UZ; Goswami C; Douce G; Fawley WN; Wilcox MH; Peto TEA; Walker AS; Crook DW
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital.
    Zhang RF; Man YX; Bai YY; Shao CH; Liu CM; Wang CH; Lei YX; Wang Y; Jin Y
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1179-1183. PubMed ID: 33563561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.
    Walbrown MA; Aspinall SL; Bayliss NK; Stone RA; Cunningham F; Squier CL; Good CB
    J Manag Care Pharm; 2008; 14(1):34-40. PubMed ID: 18240880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
    Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
    Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections.
    Corbellini S; Piccinelli G; De Francesco MA; Ravizzola G; Bonfanti C
    Folia Microbiol (Praha); 2014 Mar; 59(2):173-9. PubMed ID: 24081935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multisite genomic epidemiology study of
    Miles-Jay A; Young VB; Pamer EG; Savidge TC; Kamboj M; Garey KW; Snitkin ES
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34180789
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic resistance of clinical isolates of Clostridioides difficile in China and its association with geographical regions and patient age.
    Li H; Li WG; Zhang WZ; Yu SB; Liu ZJ; Zhang X; Wu Y; Lu JX
    Anaerobe; 2019 Dec; 60():102094. PubMed ID: 31499177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
    Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
    J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
    Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
    Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.